- References
Levoleucovorin is the enantiomerically active form of Folinic acid. A study from authors at Georgetown University have shown that there is no safety or efficacy benefit to levoleucovorin.[1] References{{Onesource|article|date=February 2015}}1. ^{{cite journal |pmid=19822510|year=2009|author1=Kovoor|first1=P. A.|title=Is levoleucovorin an alternative to racemic leucovorin? A literature review|journal=Clinical Colorectal Cancer|volume=8|issue=4|pages=200–6|last2=Karim|first2=S. M.|last3=Marshall|first3=J. L.|doi=10.3816/CCC.2009.n.034}}
{{Pharma-stub}} 2 : Chemotherapeutic adjuvants|Folates |